Tonic immobility (TI) is an innate defensive behavior that can be elicited by physical restriction and postural inversion and is characterized by a profound and temporary state of akinesis. Our previous studies demonstrated that the stimulation of serotonin receptors in the dorsal raphe nucleus (DRN) appears to be biphasic during TI responses in guinea pigs (Cavia porcellus). Serotonin released by the DRN modulates behavioral responses and its release can occur through the action of different neurotransmitter systems, including the opioidergic and GABAergic systems. This study examines the role of opioidergic, GABAergic and serotonergic signaling in the DRN in TI defensive behavioral responses in guinea pigs. Microinjection of morphine (1.1 nmol) or bicuculline (0.5 nmol) into the DRN increased the duration of TI. The effect of morphine (1.1 nmol) was antagonized by pretreatment with naloxone (0.7 nmol), suggesting that the activation of μ opioid receptors in the DRN facilitates the TI response. By contrast, microinjection of muscimol (0.5 nmol) into the DRN decreased the duration of TI. However, a dose of muscimol (0.26 nmol) that alone did not affect TI, was sufficient to inhibit the effect of morphine (1.1 nmol) on TI, indicating that GABAergic and enkephalinergic neurons interact in the DRN. Microinjection of alpha-methyl-5-HT (1.6 nmol), a 5-HT 2 agonist, into the DRN also increased TI. This effect was inhibited by the prior administration of naloxone (0.7 nmol). Microinjection of 8-OH-DPAT (1.3 nmol) also blocked the increase of TI promoted by morphine (1.1 nmol). Our results indicate that the opioidergic, GABAergic and serotonergic systems in the DRN are important for modulation of defensive behavioral responses of TI. Therefore, we suggest that opioid inhibition of GABAergic neurons results in disinhibition of serotonergic neurons and this is the mechanism by which opioids could enhance TI. Conversely, a decrease in TI could occur through the activation of GABAergic interneurons.
Introduction
Tonic immobility (TI), also known as "animal hypnosis" or "death feigning", is an innate defensive behavioral response that is characterized by profound physical inactivity and a relative lack of responsiveness to environmental stimuli. Tonic immobility may be experimentally induced by postural inversion in conjunction with slightly restricting the animal's movement. The duration of TI can vary across species and depends on environmental conditions [1] . The end of a TI episode is characterized by an abrupt restoration of the animal's typical posture [2] . This behavioral response is the last line of defense used by prey to survive during a predatory attack [3] . Confirming the efficacy of this tactic, Sargeant and Eberhardt [4] showed that 58% of wild ducks that exhibited TI when attacked by foxes (Vulpes fulva) survived the initial attack. Another indication of the adaptive value of TI was demonstrated by Thompson and colleagues [3] , who demonstrated that TI reduced the time that cats attacked quails.
Studies from our laboratory have investigated the involvement of neural structures in the TI defensive response. We have shown the involvement of different structures, including the parabrachial area, the medial hypothalamus, periaqueductal gray matter (PAG), the amygdala, the nucleus raphe magnus (NRM), the anterior cingulate cortex, the dorsal hippocampal formation (DHP, unpublished results) and the dorsal raphe nucleus (DRN) [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Recently published data show that the activation of different serotonin (5-HT) receptors in the DRN may modulate distinct aspects of the TI defensive response. Microinjection of the 5-HT 1A agonist 8-OH-DPAT into the DRN promotes a reduction in TI duration, while 5-HT 2 receptor stimulation by alpha-methyl-5-HT increases the duration of TI [13] . The DRN is located in the ventromedial PAG [14, 15] , and is one of major sources of serotonergic afferents in the forebrain and midbrain [16] . The neurotransmitter 5-HT has an important role in modulating cognitive function and affective and neuroendocrine responses [17] . The heterogeneous nature of the DRN is reflected in the variety of behaviors influenced by the 5-HT that is released from the DRN. These behaviors include sleep, sexual behavior, feeding, motor activity, pain, circadian rhythm, aggression and anxiety [15, 17] . Defensive behaviors can also be modulated by 5-HT, based on its pattern of release to different brain structures [18] , and TI seems to be highly influenced by the level of 5-HT in the brain [19] . In the DRN, serotonergic neurons are the most abundant type of neuron [14, 15] . However, neurons that release other neurotransmitters and neuromodulators are also present, including enkephalin and gammaaminobutyric acid (GABA) releasing neurons [15, [20] [21] [22] .
It is known that opioid peptides can alter extracellular levels of 5-HT. According to Grauer and colleagues [23] and Tao and Auerbach [21] , morphine microinjection into the DRN increased the extracellular concentration of 5-HT in neural areas that are innervated by this nucleus. Some studies have reported the presence of opioid receptors in the DRN [24] [25] [26] , and μ-opioids reduce GABA-mediated postsynaptic currents in 5-HT neurons [22] . GABA is the main inhibitory neurotransmitter in the brain and can be found in 40% of vertebrate neurons [27] . Tao and colleagues [28] demonstrated that GABA A and GABA B receptors are present in the DRN and could be involved in reducing 5-HT release. GABAergic afferents make inhibitory synapses directly on 5-HT neurons in the DRN [29, 30] .
Tao and Auerbach [31] showed, using microdialysis, that opioid receptor activation is responsible for 5-HT release through the inhibition of GABAergic afferents in the DRN. Another study shows that approximately 80% of DRN GABAergic cells are μ-opioid receptor immunoreactive [25] . In accordance with these results, GABAergic stimulation in the DRN of rats attenuated the increase in 5-HT release produced by morphine [32] . Neurochemical methods utilized by Tao and Auerbach [33] also showed that morphine administration into the DRN in anesthetized rats caused an increase in 5-HT metabolism and release [32, 34] and a concomitant decrease in GABA release in the DRN [35] . Therefore, GABA inhibition by morphine could facilitate serotonergic neurotransmission.
Opioid, GABA and serotonin circuits in the DRN that regulate 5-HT release in other brain areas [15] [16] [17] 32, 34, 36] could modulate defensive responses, including TI. Thus, the purpose of this study was to investigate the role of opioidergic, GABAergic and serotonergic neurons and their interactions with each other in the DRN in the modulation of tonic immobility behavioral responses in guinea pigs.
Materials and methods

Animals
In this study, we used 82 male guinea pigs (Cavia porcellus), weighing 430-480 g, from the animal care facility of Ribeirão Preto Medical School (FMRP). Throughout the experimental period, the animals were housed in plexiglass cages (56 × 37 × 39 cm, five animals per cage) lined with wood shavings, with controlled illumination (12/12 h) and temperature (24 ±1°C ). The guinea pigs had free access to food (guinea pig specific food and fresh grass) and water ad libitum. All experiments were performed in compliance with the recommendations of the College of Animal Experimentation (COBEA) and with the approval (Proc.no.089/2007) of the Ethical Committee for Animal Experimentation of the School of Medicine of Ribeirão Preto of the University of São Paulo. All efforts were made to minimize animal suffering.
Drugs
The substances morphine sulfate (opioid agonist), naloxone hydrochloride (opioid antagonist), muscimol (GABA A receptor agonist), bicuculline methiodide (GABA A receptor antagonist), 8-OH-DPAT (5-HT 1A agonist) and alpha-methyl-5-hydroxytriptamine (5-HT 2 agonist) were diluted in saline (0.9% NaCl) on the day of the experiment, according to previous studies [37] [38] [39] [40] . All substances were obtained from Sigma, St. Louis-USA.
Surgical procedures
Animals were anesthetized by intramuscular injection of both ketamine (40 mg/kg) and xylazine (5 mg/kg). Following anesthesia, we performed the dorsal head trichotomy in a stereotaxic apparatus (David-Kopf Instruments, USA) for small animals. A guide cannula was implanted in the DRN, which was located using the Rössner atlas [41] for guinea pigs: AP: +10.8 mm caudal to bregma, L: +3.0 mm lateral to the midline and P: −8.0 mm from the skull, with a 30°angle. The cannula was placed 1.0 mm dorsal to the DRN. The guide cannula was prepared from hypodermic needles segments that had a 0.6 mm outer diameter and were 14 mm long.
Microinjection procedure
We used a Hamilton microsyringe (10 μl) that was connected through a segment of polyethylene (PE 10) to a thin dental needle (Mizzi, USA) that was 15 mm long and had a 0.3 mm inner diameter. The 15 mm needle injection length extended 1 mm beyond the cannula guide and reached the DRN. The microinjection was performed in 60 s, and the needle was left in place for an additional 60 s to prevent reflux of the injected solutions. All solutions were microinjected in a total volume of 0.2 μl.
Tonic immobility recordings
The tonic immobility procedure was performed during the same period of the day, (from 13:00 to 18:00 h) to reduce variability in the results. The animals were maintained for 20 min in the experimental room prior to the start of the experiment to habituate the animal and reduce environmental stress. The animals were placed in V-shaped boxes (25 cm long × 15 cm high) that were lined with nylon foam. TI induction was performed by quickly posturally inverting the animals and then manually restraining them until the animal did not resist this procedure. At this moment, the experimenter slowly withdrew his hands and a chronometer was activated to measure (in seconds) the duration of the TI episode. The episode was determined to be over when the guinea pig returned to a habitual posture on four legs. Each naive animal was subjected to five consecutive TI inductions, with a randomized interval of between 40 and 90 s between each episode (control condition). Animals that had an average TI episode length of greater than 45 s under control conditions had a guide cannula implanted in the DRN. Five to seven days after stereotaxic surgery, the animals were submitted to a TI session in the absence of drug injection to control for postoperative effects, (sham condition). The following day, the animals were microinjected with drugs and, after each treatment, five TI episodes was again measured. A fourth day of experiments was performed when we microinjected an antagonist ten minutes before the agonist (as was the case in experiments 4, 9 and 10) prior to inducing TI. The behavioral observations started 1 min after the drugs had been microinjected.
Experimental procedures
To evaluate the effect of opioidergic stimulation in the DRN, animals were divided into four experimental groups: experiment 1 (n = 7), the animals received a microinjection of saline (NaCl 0.9%) as a vehicle control; experiment 2 (n= 10), the animals were microinjected with morphine (1.1 nmol); experiment 3, the guinea pigs were administered with naloxone (0.7 nmol) (n = 6); and experiment 4 (n = 11), the animals received a microinjection of naloxone (0.7 nmol) followed ten minutes later by a microinjection of morphine (1.1 nmol).
Three other groups of animals were tested for the role of GABA in guinea pig DRN stimulation. In experiments 5 (n = 8) and 6 (n = 11), the animals were microinjected with 0.26 and 0.5 nmol of muscimol, respectively. The animals from experiment 7 (n = 9) were pretreated with bicuculline (0.5 nmol) in the DRN.
Finally, in the last three experiments, we investigated whether the opioidergic, serotonergic and GABAergic systems interact in the DRN. In experiment 8 (n = 6), the guinea pigs were pretreated with alphamethyl-5-HT (1.6 nmol). In experiment 9 (n = 7), the animals were microinjected with naloxone (0.7 nmol) prior to the treatment of the DRN with alpha-methyl-5-HT (1.6 nmol; ten minutes). In experiment 10 (n = 7), the animals were microinjected with muscimol (0.26 nmol) followed by morphine (1.1 nmol, 10 min) in the DRN; in experiment 11 (n = 8), the animals received a microinjection of 8-OH-DPAT (1.3 nmol) followed ten minutes later by a microinjection of morphine (1.1 nmol) in the DRN.
Histological analyses
After all procedures, the animals were deeply anesthetized with sodium pentobarbital and perfused intracardially with saline followed by 10% formalin for tissue fixation. The guinea pig brains were removed and fixed in 10% formalin for 3 days followed by incubation in a solution of sucrose for three additional days. After fixation, a histological analysis was performed in which we used the Nissl coloration technique for analysis of the site of microinjection. Only guinea pigs that had their microinjection site located within the DRN according to the Rössner Atlas [41] for guinea pigs were included in the data analysis.
Statistical analyses
The TI results were expressed as the mean ± standard error of the mean (SEM) for the five TI episodes. Analysis of variance (ANOVA) for repeated measures was used for statistical analyses, and the statistical differences between groups were determined by a Duncan post-test, with the level of significance set at p b 0.05.
Results
Effect of opioidergic agonist and antagonist microinjection into the DRN
Microinjection of morphine (MS, 1.1 nmol) increased the duration of TI (Fig. 1B) . One-way ANOVA followed by Duncan post-test showed that the increase in the duration of TI after morphine microinjection was statistically significant (F (2,18) = 11.52, p = 0.0006). The increase in the duration of TI was blocked by prior microinjection of naloxone (NAL, 0.7 nmol, Fig. 1D ). An ANOVA for repeated measures indicates a significant difference between treatments (F (3,30) = 6.07, p = 0.0023), and a Duncan post-test showed that treatment with morphine was different from all other treatments (control, sham and naloxone and morphine). In contrast, the control, sham and naloxone and morphine conditions did not differ from one another (p > 0.05). In addition, the microinjection of saline and naloxone (0.7 nmol, Fig. 1C ) in the DRN of different groups of guinea pigs did not alter the mean duration of TI (p > 0.05). Fig. 2 shows a schematic representation of the saline and opioidergic agonist and antagonist microinjection sites in the guinea pig DRN.
Effect of GABAergic agonist and antagonist microinjection into the DRN
Microinjection of 0.5 nmol of muscimol (Musc) decreased the duration of TI in guinea pigs (Fig. 3Ab ). An ANOVA for repeated measures followed by Duncan post-test indicated a statistically significant difference (F (2,20) = 4.54, P = 0.0236) between the group that received muscimol and the control and sham groups. By contrast, bicuculline (BIC, 0.5 nmol) microinjection in another group of animals increased the duration of TI episodes (Fig. 3B ). An ANOVA for repeated measures followed by a Duncan post-test (F (2, 16) =17.10, p=0.0014) indicated a difference between the control and sham groups when compared to the group treated with bicuculline. However, administration of muscimol (0.26 nmol, Fig. 3Aa ) did not alter (p> 0.05) the duration of TI episodes. Fig. 3C I and II shows a schematic representation of the GABAergic agonist and antagonist microinjection sites in the guinea pig DRN.
Effect of opioidergic, GABAergic and serotonergic system interactions in the DRN on modulating the TI response
Microinjection of alpha-methyl-5-HT (Mth, 1.6 nmol) increased the duration of TI in guinea pigs (Fig. 4A) . A Duncan post-test indicated a statistically significant difference between the group that received alpha-methyl-5-HT when compared with the control and sham groups (one-way ANOVA; F (2,10) = 12.07, p = 0.0022). However, prior microinjection (10 min before) of naloxone (NAL, 0.7 nmol) blocked the increase of TI that was promoted by alpha-methyl-5-HT (Fig. 4B) . The group microinjected with 1.6 nmol of alpha-methyl-5-HT was significantly different (ANOVA, F (3,18) = 6.87, p = 0.0028) from the control, sham and naloxone and alpha-methyl-5-HT groups according to a Duncan post-test. Fig. 4C shows a schematic representation of 5-HT-opioid interactions sites in the guinea pig DRN.
Microinjection of muscimol (Musc; 0.26 nmol) 10 min before morphine (MS; 1.1 nmol) blocked the increase in TI produced by the microinjection of morphine alone in the DRN (Fig. 5A ). An ANOVA for repeated measures followed by Duncan post-test indicated a statistically significant difference (F (3,18) = 15.36; p = 0.0001) between the group that received morphine and the control, sham and muscimol and morphine groups. Prior microinjection (10 min before) of 8-OH-DPAT (DPAT, 1.3 nmol) also blocked the increase of TI that was promoted by morphine (MS; 1.1 nmol). Fig. 5B shows that the group microinjected with 1.1 nmol of morphine was significantly different (ANOVA, F (21,3) = 6.984, p = 0.002) from the control, sham and 8-OH-DPAT + morphine groups according to a Duncan post-test. Fig. 5C shows a schematic representation of opioid-GABA-5-HT interactions sites in the guinea pig DRN.
Discussion
The results of this study indicate that the opioidergic, GABAergic and serotonergic systems in the DRN are important for modulating the TI behavioral response. Morphine (1.1 nmol; opioidergic agonist) microinjection increased the duration of TI. This response was blocked by pretreatment with naloxone (0.7 nmol; opioidergic antagonist) at the same site. These data may indicate that the activation of DRN μ-opioid receptors facilitates the TI behavioral response.
Other studies have shown that systemic administration of morphine increased the duration of TI episodes in guinea pigs [42] , rats [43] , chickens [44] and rabbits [45] . Our previous work has also demonstrated that central microinjection of morphine in both ventrolateral PAG and NRM [37, 40] promoted an increase in the duration of TI in guinea pigs. These responses were blocked by the prior administration of naloxone at the same site. This indicates that in these structures, the action of morphine is probably mediated by the activation of the μ-opioid receptor subtype. These data support the results of this study that morphine increases the duration of TI. Nevertheless, a different result was observed after morphine microinjection in the central nucleus of the amygdala. Microinjection of morphine in this structure decreased the duration of TI [46] . In accordance with these results, we can assume that the opioidergic system is important in modulating the duration of TI defensive behaviors, and thus, the central nucleus of the amygdala may have an inhibitory role in TI.
Regarding the role of the GABAergic system in modulating TI behavioral responses in the DRN of guinea pigs, we found that intra-DRN microinjection of muscimol (0.5 nmol; GABA A agonist) decreased the duration of TI episodes. In contrast, bicuculline microinjection (0.5 nmol; GABA A antagonist) in the same nucleus promoted the opposite effect, (i.e., increasing TI duration). These results indicate that GABA plays a potentially inhibitory role in the DRN in mediating TI defensive behavior.
Some studies have pointed to the involvement of GABAergic circuits in the brainstem in modulating defensive behavioral responses [37, 47, 48] . Bicuculline microinjection in ventrolateral PAG, NRM or the central nucleus of the amygdala increased the duration of TI episodes, whereas muscimol injection in these same neural regions decreased this response [37, 40, 46] . These data corroborate the results of the current study because microinjection of muscimol into the DRN caused a reduction in the average duration of the TI response, while bicuculline increased this response.
The effect of GABAergic stimulation in the DRN was also verified by Sena and colleagues [44] , as they observed an increase in the escape response of rats in a T-maze test after muscimol administration into the DRN. Escape and TI are antagonistic responses because they involve different types of motor responses. In the presence of TI, the animal remains in an unusual and ungainly posture, does not move and is relatively unresponsive to external stimuli. In contrast, during the escape response, the animal exhibits intense motor activity. Thus, we suggest that the decrease in the duration of TI following GABAergic agonist (muscimol) microinjection in the DRN that we observe is in agreement with the data found in the literature.
Recently published data [13] show that microinjection of alphamethyl-5-HT (5-HT 2 agonist) in the DRN increased the duration of TI, an effect that could be blocked by the prior administration of ketanserin (5-HT 2 antagonist). In the current study, we demonstrate that an increase in TI produced by alpha-methyl-5-HT in the DRN was also blocked by prior microinjection of naloxone. Based on these findings, we can assume that stimulation of 5-HT 2 excitatory receptors possibly activates opioidergic interneurons present in the DRN. A post-synaptic inhibition exerted by naloxone on μ receptors would block the binding of enkephalin to receptors on GABAergic neurons, thus preventing the disinhibition of serotonergic neurons to enhance TI (see Fig. 6 ). Supporting this hypothesis, we observed that both morphine and alpha-methyl-5-HT microinjection increased the duration of the TI response. Our results suggest an interaction between opioidergic and serotonergic systems in the DRN in modulating the TI behavioral response in guinea pigs.
To verify the interaction between opioidergic and GABAergic systems in the DRN, we observed that the increase in the duration of TI episodes after morphine microinjection in the DRN was blocked by the prior administration of a dose of muscimol that had no effect on its own. The action of opioids in the central nervous system is predominantly inhibitory, and the effect observed after morphine administration may be due to an inhibition of tonic GABAergic activity in the DRN, which possibly releases effector neurons in the DRN. Corroborating this hypothesis, bicuculline administered in the DRN also increased the duration of TI. The previous administration of 8-OH-DPAT into the DRN of guinea pigs blocked the observed enhanced TI duration after the microinjection of morphine alone. This result reinforces our hypothesis that opioids could increase the release of 5-HT in the DRN. The activation of 5-HT1A receptors in the DRN of guinea pigs could mediate a hyperpolarization of 5-HT neurons [49] . This receptor is present on the cell soma and dendrites of 5-HT neurons and their activation by 8-OH-DPAT inhibits the release of 5-HT [50] . Thus, the microinjection of 8-OH-DPAT before the morphine prevented the disinhibition of 5-HT neurons in the DRN through the opioid activation. Thus, it is probable that the increased duration of the TI after the morphine microinjection in the DRN of guinea pigs can occur due to the release of serotonergic neurons as a result of the inhibition of GABAergic interneurons (Fig. 6 ).
Tao and Auerbach [31, 51] showed that opioids could indirectly influence serotonergic neurons of the raphe nucleus by inhibiting GABAergic afferents. Jolas and Aghajanian [22] further showed that μ-opioids reduce GABA-mediated postsynaptic currents in 5-HT neurons. Consistent with this hypothesis, Tao and Auerbach [33] found that muscimol infusion in the DRN produced a decrease in the 5-HT release produced by morphine, thus inhibiting neural activity of the DRN [52, 53] . Tao and Auerbach [54] in another study observed that the excitatory efferent pathways from the DRN are inhibited by tonically active GABAergic afferents [55, 56] . GABAergic neurons in the DRN [29, 30] are part of a feedback loop that inhibits serotonergic neurons in the DRN [57] . Thus, according to Levine and Jacobs [58] , Nitz and Siegel [59] and Gervasoni et al. [60] , GABA may be involved in decreased serotonergic discharge during sleep.
The tonically active inhibitory circuit that modulates TI defensive behavior is biologically important because the presence of this circuit would prevent the TI response from occurring at inappropriate times. This is important because this response is characterized by a profound inhibition of motor activity. Thus, only in very specific behavioral situations, such as during a prey/predator confrontation, does the prey generate a TI response. In this case, there probably would be a release of opioid peptides in the DRN which would inhibit tonic GABAergic activity, providing the necessary condition for the maintenance of the TI defensive behavioral response.
Some studies from our laboratory have demonstrated a similar circuit involving opioidergic and GABAergic neurons in other brain regions in modulating the TI behavioral response. We have highlighted the role of the ventrolateral PAG [37] , and the NRM [40] . In the current study, we assumed that the circuit involving opioids, GABA and serotonin on the DRN could be responsible for balanced 5-HT release in the projection areas of the DRN, which would be implicated in the modulation of defensive responses, such as the TI response.
The PAG receive serotonergic afferents from the DRN [61] , and this region is also involved in TI modulation [8] . Thus, a possible interpretation of our results could be a connection between the DRN and the periaqueductal gray matter, resulting in the release of serotonin in this structure and consequently the modulation of the duration of the TI response. However, we can not exclude the possibility of other 5-HT interactions in modulating this response. In other words, we can presume that the TI increase observed after morphine, bicuculline and alpha-methyl-5-HT microinjection in the DRN could occur by the activation of ascending 5-HT raphe neurons that project to other brain regions that are involved in the modulation of defensive responses. However, further studies are necessary to test this hypothesis.
In summary, our results demonstrate that opioid receptor activation by morphine microinjection into the DRN facilitates TI defensive behavioral responses in guinea pigs. In contrast, GABAergic neurotransmission acts to inhibit this response, as evidenced by a reduction in TI following muscimol administration in the DRN. Moreover, opioid action probably occurs through the inhibition of tonically active GABAergic interneurons because an ineffective dose of muscimol blocked the effect of morphine. In addition, alpha-methyl-5-HT also increased the duration of the TI response, an effect that was blocked by prior microinjection of naloxone. This observation suggests a connection between 5-HT 2 receptors and opioidergic neurons in the DRN. Within this context, we suggest a possible interaction between opioidergic, GABAergic and serotonergic systems in the DRN that composes a circuit that acts to balance the release of serotonin from the DRN, thereby modulating TI behavioral responses.
